Skip to main content
Natera, Inc. logo

Natera, Inc. — Investor Relations & Filings

Ticker · NTRA ISIN · US6323071042 LEI · 529900CQ3OZ0A0VYVU59 US Human health and social work activities
Open in API
Filings indexed 1,586 across all filing types
Latest filing 2016-03-08 Earnings Release
Country US United States of America
Listing US NTRA

About Natera, Inc.

https://www.natera.com/

Natera, Inc. is a diagnostics company specializing in cell-free DNA (cfDNA) testing. The company develops and commercializes non-invasive tests focused on three primary areas: women's health, oncology, and organ health. In women's health, its products include the Panorama non-invasive prenatal test (NIPT) and the Horizon carrier screening test to assess genetic risks. The oncology portfolio features Signatera, a personalized molecular residual disease (MRD) test used to monitor cancer recurrence and treatment response. For organ health, its tests are designed to detect early signs of transplant rejection. Natera's technology aims to provide actionable information for personalized medical care, supported by extensive clinical validation through numerous peer-reviewed studies.

Recent filings

Filing Released Lang Actions
8-K Filing
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically mentions that the company issued a press release announcing its financial results for the fourth quarter and fiscal year ended December 31, 2015. The document includes a press release as an exhibit but does not contain detailed financial statements or comprehensive analysis itself. The length is 3602 characters, which is relatively short and consistent with a current report or announcement rather than a full financial report. The document also announces the date of the upcoming Annual Meeting of Stockholders. Since the document is primarily an announcement of financial results and an event, and the actual detailed financial data is in the press release exhibit, this fits best with the category of Earnings Release (ER), which is the initial announcement of quarterly or periodical financial results with key highlights only.
2016-03-08 English
SC 13G/A Filing
Major Shareholding Notification
2016-02-22 English
4 Filing
Director's Dealing
2016-02-17 English
4 Filing
Director's Dealing
2016-02-17 English
4 Filing
Director's Dealing
2016-02-17 English
SC 13G Filing
Major Shareholding Notification
2016-02-16 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.